NYSE:CLColgate-Palmolive Stock Price, Forecast & News

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CL stock has increased by 6.9% and is now trading at $73.68. View which stocks have been most impacted by Coronavirus.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Colgate-Palmolive.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, July 31st 2020. View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive will be holding an earnings conference call on Friday, July 31st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Colgate-Palmolive (NYSE:CL) announced its quarterly earnings data on Friday, May, 1st. The company reported $0.75 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.73 by $0.02. The business earned $4.10 billion during the quarter, compared to the consensus estimate of $4.07 billion. Colgate-Palmolive had a return on equity of 942.99% and a net margin of 15.86%. The firm's revenue was up 5.5% on a year-over-year basis. During the same period last year, the firm earned $0.67 EPS. View Colgate-Palmolive's earnings history.

Colgate-Palmolive declared a quarterly dividend on Thursday, June 11th. Stockholders of record on Monday, July 20th will be given a dividend of $0.44 per share on Friday, August 14th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date is Friday, July 17th. View Colgate-Palmolive's dividend history.

15 analysts have issued twelve-month target prices for Colgate-Palmolive's stock. Their forecasts range from $58.00 to $91.00. On average, they expect Colgate-Palmolive's stock price to reach $75.54 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price. View analysts' price targets for Colgate-Palmolive.

News stories about CL stock have trended very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colgate-Palmolive earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Colgate-Palmolive.

Colgate-Palmolive saw a drop in short interest in June. As of June 30th, there was short interest totaling 12,560,000 shares, a drop of 6.8% from the June 15th total of 13,470,000 shares. Based on an average daily volume of 4,580,000 shares, the short-interest ratio is currently 2.7 days. Currently, 1.5% of the company's stock are sold short. View Colgate-Palmolive's Current Options Chain.

Some companies that are related to Colgate-Palmolive include Procter & Gamble (PG), Kimberly Clark (KMB), Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Coca-Cola (KO), Mcdonald's (MCD) and Intel (INTC).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by many different retail and institutional investors. Top institutional shareholders include Confluence Investment Management LLC (0.19%), LGT Capital Partners LTD. (0.15%), Hexavest Inc. (0.04%), Envestnet Asset Management Inc. (0.04%), Manning & Napier Group LLC (0.04%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including 6 Meridian, Hexavest Inc., Confluence Investment Management LLC, Legacy Capital Partners Inc., Bright Rock Capital Management LLC, Independent Investors Inc., Whittier Trust Co., and Global Trust Asset Management LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran. View insider buying and selling activity for Colgate-Palmolive.

CL stock was acquired by a variety of institutional investors in the last quarter, including LGT Capital Partners LTD., Envestnet Asset Management Inc., First American Trust FSB, Canandaigua National Corp, Chemung Canal Trust Co., State of Alaska Department of Revenue, Livforsakringsbolaget Skandia Omsesidigt, and Pure Financial Advisors Inc.. View insider buying and selling activity for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CL stock can currently be purchased for approximately $73.68.

Colgate-Palmolive has a market capitalization of $63.11 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]